Entity Common Stock, Shares Outstanding of ABVC BIOPHARMA, INC. from 15 Jul 2011 to 03 Mar 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ABVC BIOPHARMA, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 15 Jul 2011 to 03 Mar 2026.
  • ABVC BIOPHARMA, INC. Entity Common Stock, Shares Outstanding for the quarter ending 03 Mar 2026 was 25,440,407, a 61% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ABVC BIOPHARMA, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 25,440,407 +9,662,102 +61% 03 Mar 2026 10-K 03 Mar 2026 2025 FY
Q3 2025 24,301,089 +11,325,597 +87% 30 Oct 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 23,541,824 +11,120,009 +90% 12 Aug 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 15,778,305 +5,217,884 +49% 11 Apr 2025 10-K 15 Apr 2025 2024 FY
Q3 2024 12,975,492 +5,743,552 +79% 13 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 12,421,815 +8,470,427 +214% 14 Aug 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 10,560,421 -22,520,319 -68% 12 Mar 2024 10-K/A 15 Mar 2024 2023 FY
Q3 2023 7,231,940 -25,400,389 -78% 09 Nov 2023 10-Q 15 Nov 2023 2023 Q3
Q2 2023 3,951,388 -28,680,941 -88% 09 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 33,080,740 +2,773,411 +9.2% 31 Mar 2023 10-K 31 Mar 2023 2022 FY
Q3 2022 32,632,329 +4,022,941 +14% 11 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 32,632,329 +8,161,803 +33% 10 Aug 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 30,307,329 +5,886,803 +24% 30 Mar 2022 10-K/A 06 Jun 2022 2021 FY
Q3 2021 28,609,388 +7,795,485 +37% 12 Nov 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 24,470,526 +4,982,358 +26% 11 Aug 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 24,420,526 +4,932,358 +25% 15 Mar 2021 10-K 16 Mar 2021 2020 FY
Q3 2020 20,813,903 12 Nov 2020 10-Q 17 Nov 2020 2020 Q3
Q2 2020 19,488,168 +1,365,308 +7.5% 26 Jun 2020 10-Q 29 Jun 2020 2020 Q1
Q1 2020 19,488,168 -194,438,307 -91% 11 May 2020 10-K 15 May 2020 2019 FY
Q4 2019 19,478,168 15 Nov 2019 10-Q 18 Nov 2019 2019 Q3
Q2 2019 18,122,860 07 Aug 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 213,926,475 0 0% 08 Apr 2019 10-K 15 Apr 2019 2018 FY
Q3 2018 213,926,475 +179,828 +0.08% 13 Nov 2018 10-Q 14 Nov 2018 2018 Q3
Q1 2018 213,926,475 28 Mar 2018 10-KT 13 Apr 2018 2017 FY
Q3 2017 213,746,647 18 Aug 2017 10-Q 19 Mar 2018 2017 Q3
Q2 2017 213,746,647 +4,393,750 +2.1% 19 May 2017 10-Q/A 19 Mar 2018 2017 Q2
Q4 2016 210,821,647 +150,810,503 +251% 06 Jan 2017 10-K/A 22 Sep 2017 2016 FY
Q2 2016 209,352,897 +154,759,865 +283% 10 Aug 2016 10-Q 22 Feb 2017 2016 Q3
Q1 2016 66,422,502 +11,829,470 +22% 18 Feb 2016 10-Q 23 Feb 2016 2016 Q1
Q4 2015 60,011,144 +5,418,112 +9.9% 25 Nov 2015 10-K 27 Nov 2015 2015 FY
Q2 2015 54,593,032 31 Jul 2015 10-Q 19 Aug 2015 2015 Q3
Q1 2015 54,593,032 31 Mar 2015 10-Q 05 Jun 2015 2015 Q2
Q4 2014 54,593,032 31 Dec 2014 10-Q 17 Apr 2015 2015 Q1
Q4 2012 54,593,032 +38,261,150 +234% 31 Dec 2012 10-Q 16 Apr 2015 2013 Q1
Q2 2012 54,539,814 +43,881,308 +412% 30 Jun 2012 10-Q/A 20 Aug 2012 2012 Q3
Q4 2011 16,331,882 31 Jan 2012 10-Q 21 Feb 2012 2012 Q1
Q2 2011 10,658,506 15 Jul 2011 10-Q/A 08 Sep 2011 2011 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.